The next assassination attempt won’t be on Trump

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.

Mary Beth Fritz Biography and Net Worth

SVP of Prestige Consumer Healthcare

Mary Beth Fritz was appointed to the position of Senior Vice President, Quality & Regulatory Affairs for the Company in June 2018. Mary Beth joined Prestige Brands in 2009, serving initially as Director of Regulatory Affairs and subsequently Vice President, Product Innovation. Prior to joining the Company, Mary Beth led Regulatory Affairs for Avon Products. Her background also includes 10 years in Regulatory Affairs roles at PepsiCo including the Director of Global Regulatory Affairs, as well as various regulatory roles at Quaker Oats & Snapple Beverages. Mary Beth earned a bachelor’s degree from The Pennsylvania State University.

What is Mary Beth Fritz's net worth?: The estimated net worth of Mary Beth Fritz is at least $1.56 million as of November 12th, 2024. Ms. Fritz owns 18,835 shares of Prestige Consumer Healthcare stock worth more than $1,559,726 as of November 14th. This net worth evaluation does not reflect any other investments that Ms. Fritz may own. Learn More about Mary Beth Fritz's net worth.
How do I contact Mary Beth Fritz?: The corporate mailing address for Ms. Fritz and other Prestige Consumer Healthcare executives is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. Prestige Consumer Healthcare can also be reached via phone at (914) 524-6800 and via email at [email protected]. Learn More on Mary Beth Fritz's contact information.
Has Mary Beth Fritz been buying or selling shares of Prestige Consumer Healthcare?: In the last ninety days, Mary Beth Fritz has sold $810,273.45 in shares of Prestige Consumer Healthcare stock. Most recently, Mary Beth Fritz sold 9,885 shares of the business's stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.97, for a transaction totalling $810,273.45. Following the completion of the sale, the senior vice president now directly owns 18,835 shares of the company's stock, valued at $1,543,904.95. Learn More on Mary Beth Fritz's trading history.
Who are Prestige Consumer Healthcare's active insiders?: Prestige Consumer Healthcare's insider roster includes Mary Beth Fritz (SVP), and Ronald Lombardi (Insider). Learn More on Prestige Consumer Healthcare's active insiders.
Are insiders buying or selling shares of Prestige Consumer Healthcare?: In the last year, insiders at the sold shares 5 times. They sold a total of 33,443 shares worth more than $2,669,321.64. The most recent insider tranaction occured on November, 12th when insider William P'pool sold 8,987 shares worth more than $735,585.95. Insiders at Prestige Consumer Healthcare own 1.6% of the company. Learn More about insider trades at Prestige Consumer Healthcare.
Information on this page was last updated on 11/12/2024.

Mary Beth Fritz Insider Trading History at Prestige Consumer Healthcare

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/12/2024	Sell	9,885	$81.97	$810,273.45	18,835
3/1/2024	Sell	172	$70.42	$12,112.24	15,934
2/8/2024	Sell	5,336	$69.00	$368,184.00	15,934
9/14/2023	Sell	2,540	$58.92	$149,656.80	15,934
3/5/2021	Sell	5,759	$42.80	$246,485.20	16,499

Mary Beth Fritz Buying and Selling Activity at Prestige Consumer Healthcare

Prestige Consumer Healthcare Company Overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Today's Range

Now: $82.81

$82.04

$83.83

50 Day Range

MA: $72.98

$67.53

$82.32

2 Week Range

Now: $82.81

$56.61

$83.83

Volume

337,716 shs

Average Volume

250,663 shs

Market Capitalization

$4.09 billion

P/E Ratio

20.15

Dividend Yield

N/A

Beta

0.47